Cargando…
Dysbindin is a potent inducer of RhoA–SRF-mediated cardiomyocyte hypertrophy
Dysbindin is an established schizophrenia susceptibility gene thoroughly studied in the context of the brain. We have previously shown through a yeast two-hybrid screen that it is also a cardiac binding partner of the intercalated disc protein Myozap. Because Dysbindin is highly expressed in the hea...
Autores principales: | Rangrez, Ashraf Yusuf, Bernt, Alexander, Poyanmehr, Reza, Harazin, Violetta, Boomgaarden, Inka, Kuhn, Christian, Rohrbeck, Astrid, Frank, Derk, Frey, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840930/ https://www.ncbi.nlm.nih.gov/pubmed/24385487 http://dx.doi.org/10.1083/jcb.201303052 |
Ejemplares similares
-
RhoA Signaling in Immune Cell Response and Cardiac Disease
por: Kilian, Lucia Sophie, et al.
Publicado: (2021) -
RhoA: a dubious molecule in cardiac pathophysiology
por: Kilian, Lucia Sophie, et al.
Publicado: (2021) -
Dysbindin deficiency Alters Cardiac BLOC-1 Complex and Myozap Levels in Mice
por: Borlepawar, Ankush, et al.
Publicado: (2020) -
RhoA Regulation of Cardiomyocyte Differentiation
por: Kaarbø, Mari, et al.
Publicado: (2013) -
Data on the role of cardiac α-actin (ACTC1) gene mutations on SRF-signaling
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2020)